Document is current
Any future updates will be listed below
-
Authors
Dumitrascu, Oana M. https://orcid.org/0000-0003-2033-449X
Doustar, Jonah
Fuchs, Dieu-Trang
Koronyo, Yosef
Sherman, Dale S.
Miller, Michelle Shizu
Johnson, Kenneth O.
Carare, Roxana O.
Verdooner, Steven R.
Lyden, Patrick D.
Schneider, Julie A.
Black, Keith L.
Koronyo-Hamaoui, Maya
-
Funding
Funding for this research was provided by:
National institute of Aging (R41 AG044897, R01 AG055865)
- License Information
-
More Information
Article History
Received: 26 March 2024
Accepted: 2 June 2024
First Online: 28 June 2024
Declarations
:
: The retrospective human cohort study was approved by the Cedars-Sinai Medical Center Institutional Review Board (IRB) and was performed in accordance with the ethical standards as established in the 1964 Declaration of Helsinki and its subsequent amendments or comparable ethical standards. All human subjects provided written informed consent prior to enrollment. The eyes from deceased AD patients were obtained from Rush University’s Alzheimer’s Disease Research Center (ADRC ORA# 18011111). Histological studies were performed under the IRB protocol Pro00055802 at Cedars-Sinai Medical Center.
: Not applicable.
: Koronyo-Hamaoui, Koronyo, Verdooner, and Black are co-founding members of NeuroVision Imaging Inc., 1395 Garden Highway, Suite 250, Sacramento, CA 95833, USA. Johnson and Verdooner are employed by NeuroVision Imaging Inc. NeuroVision’s sole involvement was to provide the processed retinal images. NeuroVision did not fund this study and was not involved in the development of the novel perivascular AP methodology or analysis. All authors declare that the research study was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
